These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 667231)

  • 1. The acute effect of haloperidol and apomorphine on the severity of stuttering.
    Burns D; Brady JP; Kuruvilla K
    Biol Psychiatry; 1978 Apr; 13(2):255-64. PubMed ID: 667231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperiodl in the treatment of stuttering.
    Murray TJ; Kelly P; Campbell L; Stefanik K
    Br J Psychiatry; 1977 Apr; 130():370-3. PubMed ID: 322782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S
    Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of migraine by modulating dopamine hypersensitivity: its effect on mood and pain.
    Lai M; Loi V; Pisano MR; Del Zompo M
    Int J Clin Pharmacol Res; 1997; 17(2-3):101-3. PubMed ID: 9403364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists].
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J; Chateau R
    Rev Neurol (Paris); 1982; 138(5):409-13. PubMed ID: 7146725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9, 10-hexahydrocycloocta[b]pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects.
    Noda Y; Kurumiya S; Miura Y; Oka M
    J Pharmacol Exp Ther; 1993 May; 265(2):745-51. PubMed ID: 8098763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering.
    Gordon CT; Cotelingam GM; Stager S; Ludlow CL; Hamburger SD; Rapoport JL
    J Clin Psychiatry; 1995 Jun; 56(6):238-42. PubMed ID: 7775365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of haloperidol on ventilatory responses to dopamine in man.
    Bainbridge CW; Heistad DD
    J Pharmacol Exp Ther; 1980 Apr; 213(1):13-7. PubMed ID: 7359361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
    Janicki P; Lypko A; Szczudlik A; Libich J
    Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine, apomorphine gamma-hydroxybutyric acid, haloperidol and pimozide on reflex bradycardia in rats.
    Chen FF; Lin MT
    J Pharmacol Exp Ther; 1980 Aug; 214(2):427-32. PubMed ID: 7391987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the anti-dyskinesia effect of apomorphine in man.
    Tolosa ES
    Neurol Neurocir Psiquiatr; 1976; 17(4):223-9. PubMed ID: 138800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.